Cartilage and synovial extracellular matrix components (ECM) (ECM)

The cartilage and synovial extracellular matrix (ECM) is a complex, highly organized network of macromolecules that provides the structural framework and mechanical properties necessary for joint function. It is primarily composed of a dense meshwork of type II collagen fibers, which provide tensile strength, and large aggregating proteoglycans like aggrecan, which attract water to provide compressive resistance (Sophia Fox et al., 2009, Sports Health). In the synovial environment, components like hyaluronic acid and lubricin are essential for joint lubrication and chondrocyte protection. In degenerative conditions such as osteoarthritis, the balance between ECM synthesis and degradation is disrupted, primarily through the action of catabolic enzymes like matrix metalloproteinases (MMPs) and ADAMTS, leading to progressive tissue loss (Martel-Pelletier et al., 2016, Nature Reviews Disease Primers). Therapeutic approaches targeting the ECM include the use of viscosupplements to restore lubrication, as well as investigational anabolic agents like Sprifermin (FGF18 analog) designed to stimulate matrix production (Lohmander et al., 2014, Arthritis & Rheumatology). Biomarkers of ECM turnover, such as CTX-II and COMP, are increasingly used in clinical research to monitor disease progression and treatment efficacy (Kraus et al., 2011, Osteoarthritis and Cartilage).

Other names

Extracellular matrixArticular cartilage matrixSynovial matrixJoint ECMCartilage matrix

Viscosupplementation to restore joint lubrication, stimulation of chondrocyte-mediated matrix synthesis (anabolism), and protection against enzymatic degradation (anti-catabolism).